Herbert J. Conrad

Insider Reports History

Location
C/O Arbutus Biopharma Corp., 100 8900 Glenlyon Parkway, Burnaby, British Columbia, Canada
Signature
/s/ Sam Martin, attorney-in-fact for Herbert J. Conrad
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Herbert J. Conrad:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Matinas BioPharma Holdings, Inc. Director Stock option (right to buy) 437K Nov 1, 2023 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16.5K Jun 5, 2025 Direct
Celldex Therapeutics, Inc. Director Non-Qualified Stock Option (right to buy) 16.5K Jun 13, 2024 Direct

Insider Reports Filed by Herbert J. Conrad

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CLDX Celldex Therapeutics, Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
CLDX Celldex Therapeutics, Inc. Jun 13, 2024 1 $0 4 Jun 17, 2024 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2023 1 $0 4 Nov 3, 2023 Director
CLDX Celldex Therapeutics, Inc. Jun 15, 2023 1 $0 4 Jun 20, 2023 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 14, 2022 1 $0 4 Nov 16, 2022 Director
CLDX Celldex Therapeutics, Inc. Jun 16, 2022 1 $0 4 Jun 17, 2022 Director
MTNB Matinas BioPharma Holdings, Inc. Nov 1, 2021 1 $0 4 Nov 2, 2021 Director
MTNB Matinas BioPharma Holdings, Inc. Aug 4, 2021 4 $0 4 Jul 5, 2022 Director
MTNB Matinas BioPharma Holdings, Inc. Jul 7, 2021 2 $0 4 Jul 9, 2021 Director
MTNB Matinas BioPharma Holdings, Inc. Jun 19, 2021 3 $0 4 Jun 24, 2021 Director
CLDX Celldex Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director
MTNB Matinas BioPharma Holdings, Inc. Jan 13, 2021 6 $0 4 May 24, 2021 Director